1.Schimmer, B, et al. Large ongoing Q fever outbreak in the south of The Netherlands. Eurosurveillance 2008; 13(31).
2.Schimmer, B, et al. Sustained intensive transmission of Q fever in the south of The Netherlands. Eurosurveillance 2009; 14(9).
3.van der Hoek, W, et al. Q fever in The Netherlands: an update on the epidemiology and control measures. Eurosurveillance 2010; 15(12).
4.Dijkstra, F, et al. The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunology and Medical Microbiology 2012; 64: 3–12.
5.Dupont, HT, Thirion, X, Raoult, D. Q fever serology: cutoff determination for microimmunofluorescence. Clinical Diagnostics and Laboratory Immunology 1994; 1: 189–196.
6.Marrie, TJ, de Carolis, E. Seroepidemiology of Coxiella burnetii infection and its frequency as a cause of community-acquired pneumonia in Canada. Canadian Journal of Infectious Diseases 2002; 13: 164–166.
7.Fournier, PE, Marrie, TJ, Raoult, D. Diagnosis of Q fever. Journal of Clinical Microbiology 1998; 36: 1823–1834.
8.Schneeberger, PM, et al. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clinical and Vaccine Immunology 2010; 17: 286–290.
9.Raoult, D, Marrie, TJ, Mege, JL. Natural history and pathophysiology of Q fever. Lancet Infectious Diseases 2005; 5: 219–226.
10.Morroy, G, et al. The health status of Q fever patients after long-term follow up. BMC Infectious Diseases 2011; 11: 97.
11.van der Hoek, W, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clinical Infectious Diseases 2011; 52: 1431–1436.
12.Landais, C, et al. From acute Q fever to endocarditis: serological follow-up strategy. Clinical Infectious Diseases 2007; 44: 1337–1340.
13.Dupont, HT, et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. American Journal of Medicine 1992; 93: 427–434.
14.Teunis, PFM, et al. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479–489.
15.Edelstein-Keshet, L. Mathematical Models in Biology (Birkhauser Mathematics series). New York: McGraw-Hill Inc., 1988.
16.Simonsen, J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882–1885.
17.Teunis, PFM, et al. Biomarker dynamics: estimating infection rates from serological data. Statistics in Medicine (in press).
18.Teunis, PFM, Ogden, ID, Strachan, NJC. Hierarchical dose response of E. coli O157:H7 from human outbreaks incorporating heterogeneity in exposure. Epidemiology and Infection 2008;136: 761–770.
19.Gilks, WR, Richardson, S, Spiegelhalter, DJ (eds). Markov Chain Monte Carlo in Practice. London: Chapman & Hall, 1996.
20.Teunis, PF, et al. Usefulness of sero-surveillance for Trichinella infections in animal populations. Veterinary Parasitology 2009; 159: 345–349.
21.Sunder, S, et al. Chronic Q fever: relevance of serology. Clinical Infectious Diseases 2011; 53: 749–750.
22.Limonard, GJM, et al. One-year follow-up of patients of the ongoing Q fever outbreak: clinical, serological and echocardiographic findings. Infection 2010; 38: 471–477.
23.Hung, MN, et al. Serologic assessment of the risk of developing chronic Q fever in cohorts of acutely infected individuals. Journal of Infection 2011; 62: 39–44.